Diffuse Large B Cell Lymphoma Clinical Trials in Leiden
2 recruitingLeiden, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Diffuse Large B Cell Lymphoma
Karyopharm Therapeutics Inc244 enrolled176 locationsNCT02227251
Recruiting
Phase 2
Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL
DLBCL - Diffuse Large B Cell LymphomaNHL
University Medical Center Groningen300 enrolled7 locationsNCT05641428